Accelmed Partners is a lower middle-market private equity firm focused on acquiring and investing in U.S. commercial-stage healthtech companies. For more than a decade, we have leveraged our deep HealthTech industry experience, operational and financial expertise, and strong relationships to help management teams at companies across the medical device, tools, diagnostics, digital health and tech-enabled services sectors position their businesses for future growth and success. Our ideal partners share our values of integrity, transparency and tenacity, directed toward leveraging technology to improve patient outcomes, reduce costs and increase efficiency throughout the healthcare system.
- Healthcare
- Medical Devices
- Biotechnology
- Pharmaceuticals
- Digital Health
- Dental Industry
- Engineering
- Manufacturing
- Consulting
- Health Technology
Leadership
| Name | Title | ||
|---|---|---|---|
| Uri Geiger | Managing Partner |
in/dr-uri-geiger-ab23085
|
|
| General Partner |
|
|
|
| General Partner |
|
|
|
| General Partner |
|
|
|
| Vice President |
|
|
Recent Transactions involving Accelmed Partners
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Veranex Acquires Fusion Biotec to Continue Accelerating MedTech Diagnostic Solutions |
Fusion Biotec |
Veranex |
Lauxera Capital PartnersSummit PartnersAccelmed Partners |
Medical Device Manufacturing |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →